Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen ( (Q50803241)
Jump to navigation
Jump to search
scientific article published in June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen ( |
scientific article published in June 2013 |
Statements
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen ( (English)
1 reference
N Kumarasamy
1 reference
SECOND-LINE Study Group
1 reference
M A Boyd
1 reference
C L Moore
1 reference
C Nwizu
1 reference
M H Losso
1 reference
L Mohapi
1 reference
A Martin
1 reference
S Kerr
1 reference
A H Sohn
1 reference
H Teppler
1 reference
O Van de Steen
1 reference
J-M Molina
1 reference
S Emery
1 reference
D A Cooper
1 reference
1 June 2013
1 reference
381
1 reference
9883
1 reference
2091-2099
1 reference